Cargando…

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )

AIMS: Genetic testing in relatives of hypertrophic cardiomyopathy (HCM) patients leads to early identification of pathogenic DNA variant carriers (G+), before the onset of left ventricular hypertrophy. Routine phenotyping consists of electrocardiography (ECG) and transthoracic echocardiography (TTE)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huurman, Roy, van der Velde, Nikki, Schinkel, Arend F L, Hassing, H Carlijne, Budde, Ricardo P J, van Slegtenhorst, Marjon A, Verhagen, Judith M A, Hirsch, Alexander, Michels, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365305/ https://www.ncbi.nlm.nih.gov/pubmed/35670722 http://dx.doi.org/10.1093/ehjci/jeac099

Ejemplares similares

Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy
por: van der Velde, Nikki, et al.
Publicado: (2021)

Left-ventricular outflow tract acceleration time is associated with symptoms in patients with obstructive hypertrophic cardiomyopathy
por: Huurman, Roy, et al.
Publicado: (2020)

Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
por: Huurman, Roy, et al.
Publicado: (2022)

Effect of body surface area and gender on wall thickness thresholds in hypertrophic cardiomyopathy
por: Huurman, R., et al.
Publicado: (2019)

Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, H. G., et al.
Publicado: (2019)

Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, Hannah G., et al.
Publicado: (2018)

Improvement of late gadolinium enhancement image quality using a deep learning–based reconstruction algorithm and its influence on myocardial scar quantification
por: van der Velde, Nikki, et al.
Publicado: (2020)

Desmoplakin cardiomyopathy—an inherited cardiomyopathy presenting with recurrent episodes of acute myocardial injury
por: Schoonvelde, S. A. C., et al.
Publicado: (2022)

Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
por: Dorsch, Larissa M., et al.
Publicado: (2019)

Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
por: van der Velde, Nikki, et al.
Publicado: (2021)

Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy
por: Erden, Mustafa, et al.
Publicado: (2018)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
por: Iacovoni, Attilio, et al.
Publicado: (2012)

Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence
por: McKeown, Pascal P, et al.
Publicado: (2013)

Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging
por: Kitai, Takeshi, et al.
Publicado: (2022)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2023)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk Stratification Algorithms in Children with Hypertrophic Cardiomyopathy
por: Ziółkowska, Lidia, et al.
Publicado: (2021)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Life-long tailoring of management for patients with hypertrophic cardiomyopathy: Awareness and decision-making in changing scenarios
por: Michels, M., et al.
Publicado: (2016)

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
por: Tadros, Rafik, et al.
Publicado: (2021)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy
por: Brenes, Juan Carlos, et al.
Publicado: (2018)

Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy
por: Tarkiainen, Mika, et al.
Publicado: (2016)

Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: Thompson, Elizabeth W., et al.
Publicado: (2021)

The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy
por: Sivalokanathan, Sanjay
Publicado: (2022)

Tumoral Phenocopies of Hypertrophic Cardiomyopathy: The Role of Cardiac Magnetic Resonance
por: Bombace, Sara, et al.
Publicado: (2021)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
por: Jansen, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rrntk4f73419kj5jg73gbvgbqi